Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

A3 antibody helps identify key cells in rat hair follicle development.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Activating TLR3 boosts autophagy gene expression in skin cells.

Enhancing immune response can improve cancer treatment effectiveness.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

PDCD4 is important for controlling skin cell growth and healing.

BST2 protein and certain T cells increase in early alopecia areata.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

LRIG1 is linked to better survival in Merkel cell carcinoma.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.